CAR NK biotech Cata­ma­ran Bio to wind down, will seek part­ners for cell ther­a­pies

Off-the-shelf cell ther­a­py biotech Cata­ma­ran Bio made a “re­cent de­ci­sion to com­mence wind-down,” CEO Alvin Shih told End­points News in an email on Mon­day. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.